| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $313.0M | +27.7% |
| Cost of Revenue | $179.6M | +15.6% |
| R&D Expense | $90.9M | -15.0% |
| SG&A Expense | $218.4M | +15.1% |
| Operating Income | -$220.8M | -1.7% |
| Pre-tax Income | -$208.2M | -2.3% |
| Income Tax | $560K | -51.4% |
| Net Income | -$208.7M | -2.0% |
| EPS (Basic) | -$3.60 |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $226.3M | -21.0% |
| Short-term Investments | $50.1M | +0.3% |
| Accounts Receivable | $34.9M | -20.8% |
| Inventory | $24.1M | -24.9% |
| Current Assets | $346.8M | -18.3% |
| Total Assets | $614.3M | -20.9% |
| Current Liabilities | $71.0M | -3.2% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$64.1M | +55.0% |
| Capital Expenditures | $5.1M | -81.7% |
| Investing Cash Flow | -$3.1M | -106.1% |
| Financing Cash Flow | $6.9M | +656.3% |
| Free Cash Flow | -$69.2M | +59.4% |
| +0.0% |
| EPS (Diluted) | -$3.60 | +0.0% |
| Total Liabilities |
| $141.6M |
| -7.4% |
| Stockholders' Equity | $472.7M | -24.2% |